Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 12

2.

Update: affibody molecules for molecular imaging and therapy for cancer.

Orlova A, Feldwisch J, Abrahmsén L, Tolmachev V.

Cancer Biother Radiopharm. 2007 Oct;22(5):573-84. Review.

PMID:
17979560
3.

Production of 177Lu at the new research reactor FRM-II: Irradiation yield of 176Lu(n,gamma)177Lu.

Dvorakova Z, Henkelmann R, Lin X, Türler A, Gerstenberg H.

Appl Radiat Isot. 2008 Feb;66(2):147-51. Epub 2007 Sep 1.

PMID:
17900914
4.

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy.

Tolmachev V, Orlova A, Nilsson FY, Feldwisch J, Wennborg A, Abrahmsén L.

Expert Opin Biol Ther. 2007 Apr;7(4):555-68. Review.

PMID:
17373906
5.

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.

Tolmachev V, Orlova A, Pehrson R, Galli J, Baastrup B, Andersson K, Sandström M, Rosik D, Carlsson J, Lundqvist H, Wennborg A, Nilsson FY.

Cancer Res. 2007 Mar 15;67(6):2773-82.

6.

In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules.

Tran T, Engfeldt T, Orlova A, Widström C, Bruskin A, Tolmachev V, Karlström AE.

Bioconjug Chem. 2007 Mar-Apr;18(2):549-58. Epub 2007 Mar 2.

PMID:
17330952
7.
8.

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.

Tolmachev V, Nilsson FY, Widström C, Andersson K, Rosik D, Gedda L, Wennborg A, Orlova A.

J Nucl Med. 2006 May;47(5):846-53.

9.

The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches.

Zaczek A, Brandt B, Bielawski KP.

Histol Histopathol. 2005 Jul;20(3):1005-15. doi: 10.14670/HH-20.1005. Review.

PMID:
15944951
10.

Standardisation and decay data of 177Lu and 188Re.

Schötzig U, Schrader H, Schönfeld E, Günther E, Klein R.

Appl Radiat Isot. 2001 Jul;55(1):89-96.

PMID:
11339536
11.

HER2/neu: mechanisms of dimerization/oligomerization.

Brennan PJ, Kumagai T, Berezov A, Murali R, Greene MI.

Oncogene. 2000 Dec 11;19(53):6093-101. Review. No abstract available. Erratum in: Oncogene 2002 Jan 10;21(2):328. Kumogai T [corrected to Kumagai T].

12.

Basic science of HER-2/neu: a review.

Hung MC, Lau YK.

Semin Oncol. 1999 Aug;26(4 Suppl 12):51-9. Review.

PMID:
10482194

Supplemental Content

Support Center